BRIEF published on 07/06/2026 at 07:05, 2 months 26 days ago ReproNovo Begins EU Phase 2 Trial for Embryo Implantation Treatment ReproNovo RPN-002 Embryo Implantation NORDIC Trial Assisted Reproductive Technology
BRIEF published on 07/06/2026 at 07:05, 2 months 26 days ago ReproNovo lance un essai clinique de phase 2 dans l'UE pour son traitement d'implantation d'embryons. ReproNovo RPN-002 Implantation D'embryons Essai Nordique Techniques De Procréation Assistée
PRESS RELEASE published on 07/06/2026 at 07:00, 2 months 26 days ago ReproNovo Announces First Participant Dosed In EU Phase 2 Trial Of RPN-002 Embryo Implantation ReproNovo doses first participant in EU Phase 2 trial of RPN-002 for embryo implantation, aiming to increase IVF success rates with oxytocin receptor antagonist ReproNovo RPN-002 Embryo Implantation EU Phase 2 Trial IVF Success
BRIEF published on 03/20/2026 at 13:05, 6 months 11 days ago ReproNovo Appoints Mark Altmeyer as Chairman of the Board Biopharmaceutical Fertility Leadership ReproNovo Mark Altmeyer
BRIEF published on 03/20/2026 at 13:05, 6 months 11 days ago ReproNovo nomme Mark Altmeyer président du conseil d'administration Biopharmaceutique Direction ReproNovo Mark Altmeyer Fécondité
PRESS RELEASE published on 03/20/2026 at 13:00, 6 months 11 days ago REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD ReproNovo appoints Mark Altmeyer as Chairman of the Board. Altmeyer brings 35+ years of biopharma leadership experience across multiple therapeutic areas Chairman Fertility Biopharma ReproNovo Mark Altmeyer
BRIEF published on 09/30/2025 at 07:05, 1 year ago ReproNovo Gains Approval for RPN-001 Clinical Trial in China Clinical Trial China Approval ReproNovo Reproductive Medicine RPN-001
BRIEF published on 09/30/2025 at 07:05, 1 year ago ReproNovo obtient l'approbation pour l'essai clinique RPN-001 en Chine Essai Clinique ReproNovo RPN-001 Approbation De La Chine Médecine De La Reproduction
PRESS RELEASE published on 09/30/2025 at 07:00, 1 year ago ReproNovo Announces Clinical Trial Approval Notice for RPN-001 in China ReproNovo receives approval for RPN-001 Phase 1 trial in China from NMPA, a key step in global development for male infertility treatment. Company expanding clinical programs in the U.S. and China China Male Infertility Clinical Trial ReproNovo RPN-001
BRIEF published on 07/01/2025 at 07:05, 1 year 3 months ago ReproNovo Initiates Phase 2 Trial for Male Infertility Drug in the U.S. Male Infertility Phase 2 Trial ReproNovo RPN-001 Low Testosterone
Published on 10/01/2026 at 01:21, 6 hours 42 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 7 hours 3 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 8 hours 33 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 11 hours 28 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 16 hours 13 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 10/01/2026 at 07:50, 13 minutes ago Global launch of cosmetic product based on AFYREN’s 100% natural propionic acid
Published on 10/01/2026 at 07:46, 17 minutes ago Fresenius acquires remaining 45% of mAbxience for up to €750 million, taking full ownership of its biosimilars platform
Published on 10/01/2026 at 07:30, 33 minutes ago EVN Capital Markets Day 2026: Successfully operating in the energy market of tomorrow
Published on 10/01/2026 at 07:30, 33 minutes ago Milestone in Austria: Nordex Group receives 56 MW order from WEB Windenergie for first N175/6.X project in the country
Published on 10/01/2026 at 07:30, 33 minutes ago Mutares announces results of partial repurchase offer for outstanding Nordic Bond 2023/2027
Published on 09/30/2026 at 18:44, 13 hours 18 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 13 hours 18 minutes ago Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 13 hours 45 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 13 hours 48 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 13 hours 48 minutes ago L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms
